Back to Search
Start Over
Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial
- Source :
- Blood Advances; September 2022, Vol. 6 Issue: 18 p5356-5359, 4p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 24739529 and 24739537
- Volume :
- 6
- Issue :
- 18
- Database :
- Supplemental Index
- Journal :
- Blood Advances
- Publication Type :
- Periodical
- Accession number :
- ejs60838292
- Full Text :
- https://doi.org/10.1182/bloodadvances.2022007138